Summary
Tobias May is a biotech founder and managing director with over two decades of hands-on experience developing and commercializing novel cellular systems, including the CI-SCREEN platform that reproducibly generates functionally immortalized, phenotype-retaining cell lines across nine mammalian species. He translated a PhD and postdoctoral work at the Helmholtz Centre for Infection Research into InSCREENeX GmbH, steering technology from lab proof-of-concept to award-winning, peer-reviewed impact (including Nature Communications and the IHK-Transferpreis). Tobias blends deep technical expertise in conditional immortalization with strategic leadership, serving on multiple scientific boards and chairing ELRIG.de to connect academia, industry, and commercialization. His work uniquely enables scalable patient-derived disease cohorts and cross-species models, accelerating translational research and biotech productization.
9 years of coding experience
Diplom, Biochemistry, Diplom, Biochemistry at MLU Halle Wittenberg